Persistence of Weekly Injectable Semaglutide Use in Patients with Diabetes Mellitus and Obesity: A Retrospective Follow-Up in Colombia
Most of the patients started semaglutide at the suggested doses to continue with staging; however, the persistence of use was low, which may be related to difficulties in access, education on application methods, drug tolerability, and lack of follow-up by the clinician.
Authors
- Jorge Enrique Machado‐Alba (ORCID: https://orcid.org/0000-0002-8455-0936)
- Andrés Gaviria‐Mendoza (ORCID: https://orcid.org/0000-0003-2500-7658)
- Luis Fernando Valladales‐Restrepo (ORCID: https://orcid.org/0000-0002-4245-0101)
- Manuel Enrique Machado‐Duque (ORCID: https://orcid.org/0000-0001-8458-0986)
Institutions
- Technological University of Pereira (CO)
- Institución Universitaria Visión de las Américas (CO)
Publication Details
- Journal
- Drugs - Real World Outcomes
- Published
- 2025-10-03
- DOI
- https://doi.org/10.1007/s40801-025-00518-6
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00